Why SciSparc Ltd Stock Is Lighting Up
Portfolio Pulse from Erica Kollmann
SciSparc Ltd. (NASDAQ:SPRC) stock is surging after the company announced it received acceptance from the Australian patent office for its patent application for its Combination of Opioids and N-Acylethanolamines for pain treatment. The patent was granted by IP Australia. The company's stock has seen heavy trading volume following the announcement, with over 13 million shares traded in the session, compared to the stock's 100-day average of just over 830 thousand shares. The stock is up 67% at $5.70 at the time of publication.
October 31, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
SciSparc's stock is surging after the company received patent acceptance from the Australian patent office. The stock has seen a significant increase in trading volume and is up 67% at $5.70.
The news of the patent acceptance is a positive development for SciSparc, indicating progress in their product pipeline. This has led to increased investor interest, as evidenced by the surge in trading volume and the stock price. The stock is likely to continue its upward trajectory in the short term as the market reacts to this news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100